nodes	percent_of_prediction	percent_of_DWPC	metapath
Flavoxate—PDE8A—cardiac ventricle—dilated cardiomyopathy	0.0315	0.129	CbGeAlD
Flavoxate—PDE8A—myocardium—dilated cardiomyopathy	0.0297	0.121	CbGeAlD
Flavoxate—PDE7B—heart—dilated cardiomyopathy	0.0289	0.118	CbGeAlD
Flavoxate—PDE8B—heart—dilated cardiomyopathy	0.023	0.0942	CbGeAlD
Flavoxate—PDE8A—heart—dilated cardiomyopathy	0.0207	0.0847	CbGeAlD
Flavoxate—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.0202	0.0716	CcSEcCtD
Flavoxate—PDE4D—heart—dilated cardiomyopathy	0.0188	0.0768	CbGeAlD
Flavoxate—Drowsiness—Spironolactone—dilated cardiomyopathy	0.0182	0.0645	CcSEcCtD
Flavoxate—PDE8A—cardiac atrium—dilated cardiomyopathy	0.0177	0.0725	CbGeAlD
Flavoxate—PDE4A—heart—dilated cardiomyopathy	0.0166	0.068	CbGeAlD
Flavoxate—PDE4B—cardiac ventricle—dilated cardiomyopathy	0.0151	0.0617	CbGeAlD
Flavoxate—PDE4B—myocardium—dilated cardiomyopathy	0.0142	0.058	CbGeAlD
Flavoxate—Leukopenia—Spironolactone—dilated cardiomyopathy	0.0127	0.0451	CcSEcCtD
Flavoxate—Confusional state—Spironolactone—dilated cardiomyopathy	0.0117	0.0415	CcSEcCtD
Flavoxate—Eosinophilia—Furosemide—dilated cardiomyopathy	0.011	0.039	CcSEcCtD
Flavoxate—Somnolence—Spironolactone—dilated cardiomyopathy	0.0103	0.0366	CcSEcCtD
Flavoxate—PDE4B—heart—dilated cardiomyopathy	0.0099	0.0405	CbGeAlD
Flavoxate—Drowsiness—Furosemide—dilated cardiomyopathy	0.00988	0.0351	CcSEcCtD
Flavoxate—CHRM2—heart—dilated cardiomyopathy	0.00983	0.0402	CbGeAlD
Flavoxate—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00955	0.0339	CcSEcCtD
Flavoxate—Urticaria—Spironolactone—dilated cardiomyopathy	0.0092	0.0327	CcSEcCtD
Flavoxate—PDE4B—cardiac atrium—dilated cardiomyopathy	0.00847	0.0347	CbGeAlD
Flavoxate—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00823	0.0292	CcSEcCtD
Flavoxate—Vomiting—Spironolactone—dilated cardiomyopathy	0.00737	0.0262	CcSEcCtD
Flavoxate—Vision blurred—Furosemide—dilated cardiomyopathy	0.00728	0.0258	CcSEcCtD
Flavoxate—Headache—Spironolactone—dilated cardiomyopathy	0.00726	0.0258	CcSEcCtD
Flavoxate—Vertigo—Furosemide—dilated cardiomyopathy	0.00694	0.0246	CcSEcCtD
Flavoxate—Leukopenia—Furosemide—dilated cardiomyopathy	0.00691	0.0245	CcSEcCtD
Flavoxate—Nausea—Spironolactone—dilated cardiomyopathy	0.00688	0.0244	CcSEcCtD
Flavoxate—Dry mouth—Furosemide—dilated cardiomyopathy	0.00643	0.0228	CcSEcCtD
Flavoxate—Confusional state—Furosemide—dilated cardiomyopathy	0.00635	0.0226	CcSEcCtD
Flavoxate—Skin disorder—Furosemide—dilated cardiomyopathy	0.00612	0.0217	CcSEcCtD
Flavoxate—Tension—Lisinopril—dilated cardiomyopathy	0.00569	0.0202	CcSEcCtD
Flavoxate—Nervousness—Lisinopril—dilated cardiomyopathy	0.00563	0.02	CcSEcCtD
Flavoxate—Somnolence—Furosemide—dilated cardiomyopathy	0.0056	0.0199	CcSEcCtD
Flavoxate—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00546	0.0194	CcSEcCtD
Flavoxate—Vertigo—Lisinopril—dilated cardiomyopathy	0.00521	0.0185	CcSEcCtD
Flavoxate—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00519	0.0184	CcSEcCtD
Flavoxate—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00519	0.0184	CcSEcCtD
Flavoxate—Palpitations—Lisinopril—dilated cardiomyopathy	0.00512	0.0182	CcSEcCtD
Flavoxate—Urticaria—Furosemide—dilated cardiomyopathy	0.00501	0.0178	CcSEcCtD
Flavoxate—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00482	0.0171	CcSEcCtD
Flavoxate—Confusional state—Lisinopril—dilated cardiomyopathy	0.00477	0.0169	CcSEcCtD
Flavoxate—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00462	0.0164	CcSEcCtD
Flavoxate—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00459	0.0163	CcSEcCtD
Flavoxate—Somnolence—Lisinopril—dilated cardiomyopathy	0.0042	0.0149	CcSEcCtD
Flavoxate—Vomiting—Furosemide—dilated cardiomyopathy	0.00401	0.0142	CcSEcCtD
Flavoxate—Headache—Furosemide—dilated cardiomyopathy	0.00395	0.014	CcSEcCtD
Flavoxate—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.0039	0.0138	CcSEcCtD
Flavoxate—Urticaria—Lisinopril—dilated cardiomyopathy	0.00376	0.0133	CcSEcCtD
Flavoxate—Nausea—Furosemide—dilated cardiomyopathy	0.00374	0.0133	CcSEcCtD
Flavoxate—Vomiting—Lisinopril—dilated cardiomyopathy	0.00301	0.0107	CcSEcCtD
Flavoxate—Headache—Lisinopril—dilated cardiomyopathy	0.00296	0.0105	CcSEcCtD
Flavoxate—Nausea—Lisinopril—dilated cardiomyopathy	0.00281	0.00997	CcSEcCtD
Flavoxate—PDE7A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000878	0.00185	CbGpPWpGaD
Flavoxate—CHRM1—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.000873	0.00184	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000872	0.00184	CbGpPWpGaD
Flavoxate—CHRM2—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.000862	0.00182	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000857	0.00181	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000856	0.0018	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000853	0.0018	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000853	0.0018	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000851	0.0018	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000851	0.0018	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000851	0.0018	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.00085	0.00179	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.00085	0.00179	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00084	0.00177	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00084	0.00177	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000839	0.00177	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000837	0.00177	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000837	0.00177	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00083	0.00175	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000825	0.00174	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000818	0.00172	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000812	0.00171	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000806	0.0017	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000806	0.0017	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000793	0.00167	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000792	0.00167	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000792	0.00167	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000781	0.00165	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000778	0.00164	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000777	0.00164	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000775	0.00163	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000775	0.00163	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000768	0.00162	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000767	0.00162	CbGpPWpGaD
Flavoxate—CHRM1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000764	0.00161	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000758	0.0016	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000757	0.0016	CbGpPWpGaD
Flavoxate—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000754	0.00159	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000754	0.00159	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000745	0.00157	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000737	0.00155	CbGpPWpGaD
Flavoxate—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000725	0.00153	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00072	0.00152	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000719	0.00152	CbGpPWpGaD
Flavoxate—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000716	0.00151	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000709	0.0015	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000707	0.00149	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000704	0.00149	CbGpPWpGaD
Flavoxate—PDE8B—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000703	0.00148	CbGpPWpGaD
Flavoxate—PDE8A—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000703	0.00148	CbGpPWpGaD
Flavoxate—CHRM1—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.000701	0.00148	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000698	0.00147	CbGpPWpGaD
Flavoxate—CHRM1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000696	0.00147	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000693	0.00146	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000693	0.00146	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000676	0.00143	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000673	0.00142	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000672	0.00142	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000668	0.00141	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000656	0.00138	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000655	0.00138	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000648	0.00137	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000648	0.00137	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000646	0.00136	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000644	0.00136	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000642	0.00135	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00064	0.00135	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00064	0.00135	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00063	0.00133	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000626	0.00132	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000626	0.00132	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000626	0.00132	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000622	0.00131	CbGpPWpGaD
Flavoxate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000622	0.00131	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000621	0.00131	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000618	0.0013	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000613	0.00129	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000611	0.00129	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000603	0.00127	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000602	0.00127	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—AGT—dilated cardiomyopathy	0.000598	0.00126	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—AGT—dilated cardiomyopathy	0.000598	0.00126	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000597	0.00126	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000597	0.00126	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000596	0.00126	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000595	0.00125	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000585	0.00123	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000584	0.00123	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000582	0.00123	CbGpPWpGaD
Flavoxate—CHRM1—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.000579	0.00122	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000576	0.00122	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000574	0.00121	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000572	0.00121	CbGpPWpGaD
Flavoxate—CHRM2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000572	0.00121	CbGpPWpGaD
Flavoxate—CHRM2—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.000572	0.00121	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000565	0.00119	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000558	0.00118	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000557	0.00117	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000555	0.00117	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000549	0.00116	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000547	0.00115	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000537	0.00113	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—AGT—dilated cardiomyopathy	0.000533	0.00112	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000524	0.00111	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000522	0.0011	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00052	0.0011	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00052	0.0011	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000519	0.00109	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000515	0.00109	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000499	0.00105	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000499	0.00105	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000498	0.00105	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—AGT—dilated cardiomyopathy	0.000496	0.00105	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000495	0.00104	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000495	0.00104	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000492	0.00104	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000483	0.00102	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000483	0.00102	CbGpPWpGaD
Flavoxate—PDE8B—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000482	0.00102	CbGpPWpGaD
Flavoxate—PDE8A—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000482	0.00102	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000476	0.001	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000474	0.001	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000473	0.000998	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000468	0.000987	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000467	0.000985	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000462	0.000974	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000461	0.000972	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00046	0.00097	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000459	0.000968	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000458	0.000965	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000458	0.000965	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000455	0.000959	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000453	0.000956	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000445	0.000939	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000439	0.000925	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000435	0.000918	CbGpPWpGaD
Flavoxate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000432	0.000911	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000429	0.000906	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000425	0.000897	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000419	0.000884	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000415	0.000876	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000415	0.000876	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000412	0.000869	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.0004	0.000843	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000399	0.000842	CbGpPWpGaD
Flavoxate—CHRM1—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000397	0.000837	CbGpPWpGaD
Flavoxate—CHRM2—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000392	0.000827	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.00038	0.000802	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000379	0.0008	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000379	0.0008	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000374	0.000789	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—RAF1—dilated cardiomyopathy	0.00037	0.00078	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000366	0.000773	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000366	0.000773	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000362	0.000763	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000362	0.000763	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000361	0.000761	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.00036	0.000759	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000352	0.000742	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000351	0.00074	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000346	0.00073	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000344	0.000725	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000341	0.000718	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000338	0.000713	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000336	0.000709	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000334	0.000704	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000333	0.000702	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000333	0.000702	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.00033	0.000697	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00033	0.000696	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000328	0.000693	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000328	0.000693	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000326	0.000687	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000326	0.000687	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—AGT—dilated cardiomyopathy	0.000323	0.000681	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000314	0.000663	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.00031	0.000654	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000309	0.000652	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000305	0.000644	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.0003	0.000632	CbGpPWpGaD
Flavoxate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000296	0.000625	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000296	0.000624	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000294	0.000621	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000291	0.000614	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000287	0.000605	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000285	0.0006	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000285	0.0006	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000282	0.000594	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—AGT—dilated cardiomyopathy	0.000281	0.000593	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—RAC1—dilated cardiomyopathy	0.00028	0.000591	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000278	0.000587	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—AGT—dilated cardiomyopathy	0.000268	0.000564	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000267	0.000564	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000264	0.000557	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.00026	0.000549	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000259	0.000547	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000256	0.00054	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000254	0.000535	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000253	0.000533	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—AGT—dilated cardiomyopathy	0.000248	0.000522	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000243	0.000512	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00024	0.000505	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000236	0.000497	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000227	0.000478	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000224	0.000473	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000221	0.000467	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000219	0.000461	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000216	0.000455	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000208	0.000438	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000205	0.000432	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000199	0.000421	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000198	0.000418	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000197	0.000415	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000197	0.000415	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000196	0.000413	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000195	0.000412	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000194	0.000409	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000194	0.000409	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000188	0.000397	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000186	0.000392	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000186	0.000392	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000183	0.000385	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00018	0.00038	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00018	0.00038	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000178	0.000375	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000177	0.000373	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000175	0.000368	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000172	0.000362	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000154	0.000324	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000151	0.000319	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000149	0.000315	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000143	0.000302	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000142	0.000299	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000134	0.000282	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000127	0.000269	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000125	0.000264	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000123	0.00026	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000123	0.00026	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000122	0.000257	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000118	0.000249	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000111	0.000235	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—RAC1—dilated cardiomyopathy	0.00011	0.000232	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000106	0.000224	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—AGT—dilated cardiomyopathy	0.000105	0.000221	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.57e-05	0.000181	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.46e-05	0.000178	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	7.38e-05	0.000156	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—RAF1—dilated cardiomyopathy	7.29e-05	0.000154	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	5.06e-05	0.000107	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—EGFR—dilated cardiomyopathy	5e-05	0.000105	CbGpPWpGaD
